First Ever Publicly Traded Psychedelics Company Soars over 22% on First Day of Trading


Mark IX Senior Status
Founding Member
Founding Vendor
Feb 22, 2020

Mind Medicine, the first ever psychedelic medicine company to be publicly traded, soared over 22% on its’ first day of trading on the NEO Canadian stock exchange today. Trading under the symbol MMED on the NEO, Mind Medicine was up 22.7% today on its’ first day of trading, ending the day at $0.41.

Continue reading...